Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance
- 1 September 2019
- Vol. 51 (3) , 548-560.e4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Alliance for Cancer Gene Therapy
- Stand Up To Cancer
This publication has 64 references indexed in Scilit:
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory DevelopmentImmunity, 2012
- Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1Immunity, 2010
- Central leptin action improves skeletal muscle AKT, AMPK, and PGC1α activation by hypothalamic PI3K-dependent mechanismMolecular and Cellular Endocrinology, 2010
- Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cellsBlood, 2009
- Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumoursGene Therapy, 2009
- Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activationMolecular Immunology, 2009
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parametersNature Medicine, 2009
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- Targeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia VirusPLOS Medicine, 2007
- Obesity Genes: Beneficial Effects in Heterozygous MiceScience, 1979